Siemens Atellica™ CH Barbiturates (Brb)

Country: Singapore

Language: English

Source: HSA (Health Sciences Authority)

Available from:

SIEMENS HEALTHCARE PTE. LTD.

Class:

Class B IVD

Manufactured by:

Siemens Healthcare Diagnostics Inc

Therapeutic area:

Clinical toxicology

Therapeutic indications:

The Atellica® CH Barbiturates (Brb) assay is a homogeneous enzyme immunoassay with a 200 ng/mL or 300 ng/mL cutoff. The Brb assay is for in vitro diagnostic use in the qualitative or semiquantitative analyses of barbiturates in human urine using the Atellica® Analyzers.

Product summary:

Device System Info:[Device with measuring function], [System or Procedure Pack]; Models: Atellica CH Barbiturates (Brb) - 11097507, Emit Calibrator/Control Level 0 - 10445406 (9A509UL), Emit Calibrator/Control Level 2 - 10445408 (9A549UL), Emit Calibrator/Control Level 3 - 10445409 (9A569UL), Emit Calibrator/Control Level 4 - 10445410 (9A589UL), Emit Calibrator/Control Level 5 - 10445411 (9A609UL)

Authorization date:

2017-12-11